DrugPatentWatch Database PreviewSee Plans and Pricing
« Back to Dashboard
Fondaparinux sodiumis the generic ingredient in two branded drugs marketed by Mylan Ireland Ltd, Aurobindo Pharma Ltd, Dr Reddys Labs Ltd, Jiangsu Hengrui Med, and Scinopharm Taiwan, and is included in five NDAs. Additional information is available in the individual branded drug profile pages.
There are fourteen drug master file entries for fondaparinux sodium. Seven suppliers are listed for this compound.
Recent Clinical Trials for fondaparinux sodium
Identify potential brand extensions & 505(b)(2) entrants
|Prairie Education and Research Cooperative||N/A|
|American College of Phlebology||N/A|
Pharmacology for fondaparinux sodium
|Drug Class||Factor Xa Inhibitor |
|Mechanism of Action||Factor Xa Inhibitors |
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||TE||Type||RLD||RS||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Exclusivity Expiration|
|Aurobindo Pharma Ltd||FONDAPARINUX SODIUM||fondaparinux sodium||INJECTABLE;SUBCUTANEOUS||206918-002||Dec 26, 2017||AP||RX||No||No||Start Trial||Start Trial||Start Trial|
|Mylan Ireland Ltd||ARIXTRA||fondaparinux sodium||INJECTABLE;SUBCUTANEOUS||021345-002||May 28, 2004||AP||RX||Yes||Yes||Start Trial||Start Trial||Start Trial|
|Jiangsu Hengrui Med||FONDAPARINUX SODIUM||fondaparinux sodium||INJECTABLE;SUBCUTANEOUS||206812-003||May 15, 2018||AP||RX||No||No||Start Trial||Start Trial||Start Trial|
|Mylan Ireland Ltd||ARIXTRA||fondaparinux sodium||INJECTABLE;SUBCUTANEOUS||021345-003||May 28, 2004||AP||RX||Yes||Yes||Start Trial||Start Trial||Start Trial|
|>Applicant||>Tradename||>Generic Name||>Dosage||>NDA||>Approval Date||>TE||>Type||>RLD||>RS||>Patent No.||>Patent Expiration||>Product||>Substance||>Delist Req.||>Exclusivity Expiration|
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||Patent No.||Patent Expiration|
|Mylan Ireland Ltd||ARIXTRA||fondaparinux sodium||INJECTABLE;SUBCUTANEOUS||021345-001||Dec 7, 2001||Start Trial||Start Trial|
|>Applicant||>Tradename||>Generic Name||>Dosage||>NDA||>Approval Date||>Patent No.||>Patent Expiration|
Make Better Decisions: Try a trial or see plans & pricing
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.